Twin Securities’s Day One Biopharmaceuticals DAWN Stock Holding History

Twin Securities’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-31,626	Closed	-$678K	–	17
2026 Q1	$678K	Buy	+31,626	New	+$446K	0.33%	13

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Twin Securities's DAWN Position: Q2 2026 in Review

Twin Securities sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 31,626 shares — an estimated $678K sold.

Twin Securities first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $678K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Twin Securities reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Twin Securities sold 31,626 Day One Biopharmaceuticals shares in Q2 2026, an estimated $678K.
Twin Securities first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Twin Securities's Day One Biopharmaceuticals position peaked at $678K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Twin Securities's 13F filing for Q2 2026, filed 14 Aug 2026.